Skip to main content
SpringerLink
Log in

Prognostic impact of Auer rods for cytoreductive chemotherapy and myeloablative allogeneic stem cell transplantation in adult patients with myelodysplastic syndrome with excess blasts-2

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Garcia-Manero G, Chien KS, Montalban-Bravo G (2020) Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management. Am J Hematol 95(11):1399–1420. https://doi.org/10.1002/ajh.25950

    Article  PubMed  Google Scholar 

  2. Kroger N (2019) Induction, bridging, or straight ahead: the ongoing dilemma of allografting in advanced myelodysplastic syndrome. Biol Blood Marrow Transplant 25(8):e247–e249. https://doi.org/10.1016/j.bbmt.2019.06.016

    Article  PubMed  Google Scholar 

  3. Schroeder T, Wegener N, Lauseker M, Rautenberg C, Nachtkamp K, Schuler E, Kondakci M, Haas R, Germing U, Kobbe G (2019) Comparison between upfront transplantation and different pretransplant cytoreductive treatment approaches in patients with high-risk myelodysplastic syndrome and secondary acute myelogenous leukemia. Biol Blood Marrow Transplant 25(8):1550–1559. https://doi.org/10.1016/j.bbmt.2019.03.011

    Article  PubMed  Google Scholar 

  4. Sun YQ, Xu LP, Liu KY, Zhang XH, Yan CH, Jin J, Huang XJ, Wang Y (2021) Pre-transplantation cytoreduction does not benefit advanced myelodysplastic syndrome patients after myeloablative transplantation with grafts from family donors. Cancer Commun (Lond) 41(4):333–344. https://doi.org/10.1002/cac2.12140

    Article  Google Scholar 

  5. Ye L, Ren Y, Zhou X, Mei C, Ma L, Ye X, Wei J, Xu W, Meng H, Qian W, Mai W, Lou Y, Xu G, Qian J, Lou Y, Luo Y, Xie L, Lin P, Hu C, Jin J, Tong H (2017) Decitabine priming prior to low-dose chemotherapy improves patient outcomes in myelodysplastic syndromes-RAEB: a retrospective analysis vs. chemotherapy alone. J Cancer Res Clin Oncol 143(5):873–882. https://doi.org/10.1007/s00432-016-2331-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Meng T, Qi J, Zhu Y, Xu Y, Chen F, Xue S, Miao M, Chen S, Han Y, Tang X, Qiu H, Sun A, Wu D, Wang Y (2021) Impact of disease status at allogeneic stem cell transplantation on adolescent and young adult patients with early T-cell precursor acute lymphoblastic leukemia. Hematol Oncol 39(3):358–363. https://doi.org/10.1002/hon.2841

    Article  CAS  PubMed  Google Scholar 

  7. Cheson BD, Greenberg PL, Bennett JM, Lowenberg B, Wijermans PW, Nimer SD, Pinto A, Beran M, de Witte TM, Stone RM, Mittelman M, Sanz GF, Gore SD, Schiffer CA, Kantarjian H (2006) Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood 108(2):419–425. https://doi.org/10.1182/blood-2005-10-4149

    Article  CAS  PubMed  Google Scholar 

  8. Yoshida Y, Oguma S, Ohno H (2009) John Auer and Auer rods; controversies revisited. Leuk Res 33(5):614–616. https://doi.org/10.1016/j.leukres.2008.09.014

    Article  PubMed  Google Scholar 

  9. Schuler E, Zadrozny N, Blum S, Schroeder T, Strupp C, Hildebrandt B, Kundgen A, Gattermann N, Aul C, Kondakci M, Kobbe G, Haas R, Germing U (2018) Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapy. Ann Hematol 97(12):2325–2332. https://doi.org/10.1007/s00277-018-3466-7

    Article  PubMed  Google Scholar 

  10. Huang H, Qin T, Xu Z, Shi Z, Li B, Pan L, Hu N, Qu S, Huang G, Gale RP, Xiao Z (2020) Mutational features of myelodysplastic syndromes with Auer rods reveal them are more akin to acute myeloid leukemia. Br J Haematol 188(5):796–800. https://doi.org/10.1111/bjh.16326

    Article  PubMed  Google Scholar 

  11. Germing U, Strupp C, Kuendgen A, Aivado M, Giagounidis A, Hildebrandt B, Aul C, Haas R, Gattermann N (2006) Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals. Br J Haematol 132(2):162–167. https://doi.org/10.1111/j.1365-2141.2005.05853.x

    Article  PubMed  Google Scholar 

  12. Della Porta MG, Galli A, Bacigalupo A, Zibellini S, Bernardi M, Rizzo E, Allione B, van Lint MT, Pioltelli P, Marenco P, Bosi A, Voso MT, Sica S, Cuzzola M, Angelucci E, Rossi M, Ubezio M, Malovini A, Limongelli I, Ferretti VV, Spinelli O, Tresoldi C, Pozzi S, Luchetti S, Pezzetti L, Catricala S, Milanesi C, Riva A, Bruno B, Ciceri F, Bonifazi F, Bellazzi R, Papaemmanuil E, Santoro A, Alessandrino EP, Rambaldi A, Cazzola M (2016) Clinical effects of driver somatic mutations on the outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem-cell transplantation. J Clin Oncol 34(30):3627–3637. https://doi.org/10.1200/JCO.2016.67.3616

    Article  PubMed  PubMed Central  Google Scholar 

  13. Lindsley RC, Saber W, Mar BG, Redd R, Wang T, Haagenson MD, Grauman PV, Hu ZH, Spellman SR, Lee SJ, Verneris MR, Hsu K, Fleischhauer K, Cutler C, Antin JH, Neuberg D, Ebert BL (2017) Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation. N Engl J Med 376(6):536–547. https://doi.org/10.1056/NEJMoa1611604

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Willis MS, McKenna RW, Peterson LC, Coad JE, Kroft SH (2005) Low blast count myeloid disorders with Auer rods: a clinicopathologic analysis of 9 cases. Am J Clin Pathol 124(2):191–198. https://doi.org/10.1309/WB79-MFV6-FCDJ-H2EG

    Article  PubMed  Google Scholar 

Download references

Funding

This work was supported by grants from the National Natural Science Foundation of China (81,730,003, 81,870,120, 81,670,164), the Natural Science Foundation of Jiangsu Province (BK20171205), the Social Development Project of Jiangsu Province (BE2019655), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and the National Key Research and Development Program (2017ZX09304021, 2017YFA0104500, 2019YFC0840604). All the samples were from Jiangsu Biobank of Clinical Resources.

Author information

Authors and Affiliations

  1. National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, No. 188 Shizi Street, Suzhou, 215000, China

    Yi Wang, Yaoyao Shen, Jiaqian Qi, Jia Chen, Yang Xu, Feng Chen, Xiao Ma, Miao Miao, Shengli Xue, Huiying Qiu, Xiaowen Tang, Yue Han, Suning Chen, Aining Sun, Depei Wu & Ying Wang

  2. Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China

    Yaoyao Shen, Jiaqian Qi, Jia Chen, Yang Xu, Feng Chen, Shengli Xue, Huiying Qiu, Xiaowen Tang, Yue Han, Suning Chen, Aining Sun, Depei Wu & Ying Wang

  3. Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China

    Yang Xu, Xiaowen Tang, Yue Han, Suning Chen, Depei Wu & Ying Wang

  4. Department of Hematology, The Affiliated Huai’an Hospital of Xuzhou Medical University and The Second People’s Hospital of Huai’an, No 62, Huaihai Road (S.), Huai’an, China

    Yanming Zhang

  5. State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, China

    Depei Wu & Ying Wang

Authors
  1. Yi Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yaoyao Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jiaqian Qi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jia Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yang Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Feng Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xiao Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Miao Miao
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shengli Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Huiying Qiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Xiaowen Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yue Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Suning Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Aining Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Yanming Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Depei Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Ying Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Yi Wang designed and performed the research study, analyzed the data, and wrote the manuscript. Yaoyao Shen and Jiaqian Qi completed the research study and analyzed the data. Jia Chen, Yang Xu, Feng Chen, Xiao Ma, Miao Miao, and Shengli Xue contributed to the data analysis and manuscript writing. Huiying Qiu, Xiaowen Tang, Yue Han, Suning Chen, Aining Sun, and Yanming Zhang contributed to the external validation. Ying Wang and Depei Wu contributed to the research design, data analysis, writing the manuscript, and supervision of the study.

Corresponding authors

Correspondence to Depei Wu or Ying Wang.

Ethics declarations

Ethics approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Yi Wang, Yaoyao Shen, and Jiaqian Qi are co-first authors

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 199 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, Y., Shen, Y., Qi, J. et al. Prognostic impact of Auer rods for cytoreductive chemotherapy and myeloablative allogeneic stem cell transplantation in adult patients with myelodysplastic syndrome with excess blasts-2. Ann Hematol 101, 1611–1615 (2022). https://doi.org/10.1007/s00277-022-04808-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-022-04808-9

Search

Navigation